Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders

Neuroscience Research

Volumn 64, Issue 2, 2009, Pages 162-169

  Rout, Ujjwal K ^a   Clausen, Pete ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Marligen Biosciences   (United States)

Author keywords

Alcohol; Autism; Dopamine; GATA; Serotonin; Thalidomide; Transcription; Valproate

Indexed keywords

ALCOHOL; THALIDOMIDE; TRANSCRIPTION FACTOR GATA 3; VALPROIC ACID;

ANIMAL CELL; ARTICLE; AUTISM; BRAIN DEVELOPMENT; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; TERATOGENESIS; WESTERN BLOTTING;

ANIMALS; AUTISTIC DISORDER; ETHANOL; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; PC12 CELLS; PROTEIN BINDING; RATS; TERATOGENS; THALIDOMIDE; TRANSCRIPTION FACTORS; VALPROIC ACID;

EID: 67349203862     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.02.009     Document Type: Article

References (75)

1. Abu-Akel A. The neurochemical hypothesis of 'theory of mind'. Med. Hypotheses 60 (2003) 382-386
2. Ansorge M., Tanneberger C., Davies B., Theuring F., and Kusserow H. Analysis of the murine 5-HT receptor gene promoter in vitro and in vivo. Eur. J. Neurosci. 20 (2004) 363-374
3. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. Int. J. Dev. Neurosci. 23 (2005) 189-199
4. Awatsuji H., Furukawa Y., Hirota M., Murakami Y., Nii S., Furukawa S., and Hayashi K. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J. Neurosci. Res. 34 (1993) 539-545
5. Blaxill M.F., Baskin D.S., and Spitzer W.O. Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), the changing prevalence of autism in California. J. Autism Dev. Disord. 33 (2003) 223-226 discussion 227-229
6. Boddaert N., Belin P., Chabane N., Poline J.B., Barthelemy C., Mouren-Simeoni M.C., Brunelle F., Samson Y., and Zilbovicius M. Perception of complex sounds: abnormal pattern of cortical activation in autism. Am. J. Psychiatry 160 (2003) 2057-2060
7. Brodie C., Goldreich N., Haiman T., and Kazimirsky G. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J. Neuroimmunol. 81 (1998) 20-30
8. Chung F., Lu J., Palmer B.D., Kestell P., Browett P., Baguley B.C., Tingle M., and Ching L.M. Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients. Clin. Cancer Res. 10 (2004) 5949-5956
9. Cook E.H. Autism: review of neurochemical investigation. Synapse 6 (1990) 292-308
10. Cote F., Schussler N., Boularand S., Peirotes A., Thevenot E., Mallet J., and Vodjdani G. Involvement of NF-Y and Sp1 in basal and cAMP-stimulated transcriptional activation of the tryptophan hydroxylase (TPH) gene in the pineal gland. J. Neurochem. 81 (2002) 673-685
11. Dhossche D.M., and Rout U. Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT. Int. Rev. Neurobiol. 72 (2006) 55-79
12. Edvinsson L., Degueurce A., Duverger D., MacKenzie E.T., and Scatton B. Central serotonergic nerves project to the pial vessels of the brain. Nature 306 (1983) 55-57
13. Faro L.R., do Nascimento J.L., San Jose J.M., Alfonso M., and Duran R. Intrastriatal administration of methylmercury increases in vivo dopamine release. Neurochem. Res. 25 (2000) 225-229
14. Fatemi S.H., Pearce D.A., Brooks A.I., and Sidwell R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57 (2005) 91-99
15. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., Smee D.F., Pearce D.A., Winter C., Sohr R., and Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 99 (2008) 56-70
16. Figg W.D., Raje S., Bauer K.S., Tompkins A., Venzon D., Bergan R., Chen A., Hamilton M., Pluda J., and Reed E. Pharmacokinetics of thalidomide in an elderly prostate cancer population. J. Pharm. Sci. 88 (1999) 121-125
17. Finotto S., De Sanctis G.T., Lehr H.A., Herz U., Buerke M., Schipp M., Bartsch B., Atreya R., Schmitt E., Galle P.R., Renz H., and Neurath M.F. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193 (2001) 1247-1260
18. Fulginiti S., Vigliecca N.S., and Minetti S.A. Acute ethanol intoxication during pregnancy: postnatal effects on the behavioral response to serotonin agents. Alcohol 9 (1992) 523-527
19. Gendreau P.L., Petitto J.M., Petrova A., Gariepy J., and Lewis M.H. D(3) and D(2) dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice. Behav. Brain Res. 114 (2000) 107-117
20. George K.M., Leonard M.W., Roth M.E., Lieuw K.H., Kioussis D., Grosveld F., and Engel J.D. Embryonic expression and cloning of the murine GATA-3 gene. Development 120 (1994) 2673-2686
21. Gomot M., Belmonte M.K., Bullmore E.T., Bernard F.A., and Baron-Cohen S. Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain 131 (2008) 2479-2488
22. Gupta A.R., and State M.W. Recent advances in the genetics of autism. Biol. Psychiatry 61 (2007) 429-437
23. Hard M.L., Abdolell M., Robinson B.H., and Koren G. Gene-expression analysis after alcohol exposure in the developing mouse. J. Lab. Clin. Med. 145 (2005) 47-54
24. Heils A., Teufel A., Petri S., Seemann M., Bengel D., Balling U., Riederer P., and Lesch K.P. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural. Transm. Gen. Sect. 102 (1995) 247-254
25. Heils A., Wichems C., Mossner R., Petri S., Glatz K., Bengel D., Murphy D.L., and Lesch K.P. Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons. J. Neurochem. 70 (1998) 932-939
26. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., van de Water J., and Pessah I.N. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ. Health Perspect. 114 (2006) 1119-1125
27. Honda H., Shimizu Y., Misumi K., Niimi M., and Ohashi Y. Cumulative incidence and prevalence of childhood autism in children in Japan. Br. J. Psychiatry 169 (1996) 228-235
28. Hong S.J., Choi H.J., Hong S., Huh Y., Chae H., and Kim K.S. Transcription factor GATA-3 regulates the transcriptional activity of dopamine beta-hydroxylase by interacting with Sp1 and AP4. Neurochem. Res. 33 (2008) 1821-1831
29. Hong S.J., Huh Y., Chae H., Hong S., Lardaro T., and Kim K.S. GATA-3 regulates the transcriptional activity of tyrosine hydroxylase by interacting with CREB. J. Neurochem. 98 (2006) 773-781
30. Ingram J.L., Peckham S.M., Tisdale B., and Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22 (2000) 319-324
31. Karis A., Pata I., van Doorninck J.H., Grosveld F., de Zeeuw C.I., de Caprona D., and Fritzsch B. Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear. J. Comp. Neurol. 429 (2001) 615-630
32. Kawamoto, J., Kimura, F., Yoshitomi, H., Shimizu, H., Yoshidome, H., Ohtsuka, M., Kato, A., Nozawa, S., Furukawa, K., Mitsuhashi, N., Takeuchi, D., Miyazaki, M., 2008. Preoperative GATA3 mRNA expression in peripheral blood mononuclear cells is up-regulated in patients with postoperative infection following hepatobiliary pancreatic surgery. J. Surg. Res., in press.
33. Kim H.S., Seo H., Yang C., Brunet J.F., and Kim K.S. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites. J. Neurosci. 18 (1998) 8247-8260
34. Lawson M.A., and Mellon P.L. Expression of GATA-4 in migrating gonadotropin-releasing neurons of the developing mouse. Mol. Cell. Endocrinol. 140 (1998) 157-161
35. Leventhal B.L., Cook Jr. E.H., Morford M., Ravitz A., and Freedman D.X. Relationships of whole blood serotonin and plasma norepinephrine within families. J. Autism Dev. Disord. 20 (1990) 499-511
36. Li H., Radford J.C., Ragusa M.J., Shea K.L., McKercher S.R., Zaremba J.D., Soussou W., Nie Z., Kang Y.J., Nakanishi N., Okamoto S., Roberts A.J., Schwarz J.J., and Lipton S.A. Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 9397-9402
37. Lim K.C., Lakshmanan G., Crawford S.E., Gu Y., Grosveld F., and Engel J.D. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 25 (2000) 209-212
38. Lovett-Racke A.E., Smith M.E., Arredondo L.R., Bittner P.S., Ratts R.B., Shive C.L., Forsthuber T.G., and Racke M.K. Developmentally regulated gene expression of Th2 cytokines in the brain. Brain Res. 870 (2000) 27-35
39. McNamara I.M., Borella A.W., Bialowas L.A., and Whitaker-Azmitia P.M. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res. 1189 (2008) 203-214
40. Miyazaki K., Narita N., and Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 23 (2005) 287-297
41. Moriguchi T., Takako N., Hamada M., Maeda A., Fujioka Y., Kuroha T., Huber R.E., Hasegawa S.L., Rao A., Yamamoto M., Takahashi S., Lim K.C., and Engel J.D. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development 133 (2006) 3871-3881
42. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) e472-486
43. Nardelli J., Thiesson D., Fujiwara Y., Tsai F.Y., and Orkin S.H. Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev. Biol. 210 (1999) 305-321
44. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., and Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52 (2002) 576-579
45. Nawijn M.C., Dingjan G.M., Ferreira R., Lambrecht B.N., Karis A., Grosveld F., Savelkoul H., and Hendriks R.W. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J. Immunol. 167 (2001) 724-732
46. Neave B., Rodaway A., Wilson S.W., Patient R., and Holder N. Expression of zebrafish GATA 3 (gta3) during gastrulation and neurulation suggests a role in the specification of cell fate. Mech. Dev. 51 (1995) 169-182
47. Oosterwegel M., Timmerman J., Leiden J., and Clevers H. Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev. Immunol. 3 (1992) 1-11
48. Ozawa H., Tamauchi H., Ito M., Terashima M., Inoue M., Hozumi K., Habu S., and Watanabe N. Immune responses to Nippostrongylus brasiliensis and tuberculin protein in GATA-3-transgenic mice. Immunol. Lett. 99 (2005) 228-235
49. Pandolfi P.P., Roth M.E., Karis A., Leonard M.W., Dzierzak E., Grosveld F.G., Engel J.D., and Lindenbaum M.H. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11 (1995) 40-44
50. Paton A. Alcohol in the body. BMJ 330 (2005) 85-87
51. Previc F.H. Prenatal influences on brain dopamine and their relevance to the rising incidence of autism. Med. Hypotheses 68 (2007) 46-60
52. Puizillout J.J., Gaudin-Chazal G., Sayadi A., and Vigier D. Serotoninergic mechanisms and sleep. J. Physiol. (Paris) 77 (1981) 415-424
53. Quenby S.M., Anin S., Bates M.D., Chadwick D., Vince G.S., and Neilson J.P. Phenytoin but not valproate directly affected in vitro trophoblast differentiation. Eur. J. Obstet. Gynecol. Reprod. Biol. 137 (2008) 31-36
54. Rehm J., Rehn N., Room R., Monteiro M., Gmel G., Jernigan D., and Frick U. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur. Addict. Res. 9 (2003) 147-156
55. Ridley R.M., and Baker H.F. Stereotypy in monkeys and humans. Psychol. Med. 12 (1982) 61-72
56. Rodier P.M., Ingram J.L., Tisdale B., and Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 11 (1997) 417-422
57. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., and Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370 (1996) 247-261
58. Rout U.K. Valproate, thalidomide and ethyl alcohol alter the migration of HTR-8/SVneo cells. Reprod. Biol. Endocrinol. 4 (2006) 44
59. Rowland T.L., McHugh S.M., Deighton J., Ewan P.W., Dearman R.J., and Kimber I. Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B. Int. Immunopharmacol. 1 (2001) 49-61
60. Schneider T., and Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
61. Shurin G.V., Ferris R.L., Tourkova I.L., Perez L., Lokshin A., Balkir L., Collins B., Chatta G.S., and Shurin M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol. 174 (2005) 5490-5498
62. Smalley S.L., Asarnow R.F., and Spence M.A. Autism and genetics. A decade of research. Arch. Gen. Psychiatry 45 (1988) 953-961
63. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann. N.Y. Acad. Sci. 836 (1997) 220-232
64. Tamauchi H., Terashima M., Ito M., Maruyama H., Ikewaki N., Inoue M., Gao X., Hozumi K., and Habu S. Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response. Int. Immunol. 16 (2004) 179-187
65. Trottier G., Srivastava L., and Walker C.D. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J. Psychiatry Neurosci. 24 (1999) 103-115
66. Tsarovina K., Pattyn A., Stubbusch J., Muller F., van der Wees J., Schneider C., Brunet J.F., and Rohrer H. Essential role of Gata transcription factors in sympathetic neuron development. Development 131 (2004) 4775-4786
67. van Doorninck J.H., van Der Wees J., Karis A., Goedknegt E., Engel J.D., Coesmans M., Rutteman M., Grosveld F., and De Zeeuw C.I. GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei. J. Neurosci. 19 (1999) RC12
68. Veasey S.C., Fornal C.A., Metzler C.W., and Jacobs B.L. Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats. J. Neurosci. 15 (1995) 5346-5359
69. Volkmar F.R. Pharmacological interventions in autism: theoretical and practical issues. J. Clin. Child. Psychol. 30 (2001) 80-87
70. Vorhees C.V., Weisenburger W.P., and Minck D.R. Neurobehavioral teratogenic effects of thalidomide in rats. Neurotoxicol. Teratol. 23 (2001) 255-264
71. Wada K., Nakajima A., Katayama K., Kudo C., Shibuya A., Kubota N., Terauchi Y., Tachibana M., Miyoshi H., Kamisaki Y., Mayumi T., Kadowaki T., and Blumberg R.S. Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 (2006) 12673-12681
72. Wagner G.C., Reuhl K.R., Cheh M., McRae P., and Halladay A.K. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J. Autism Dev. Disord. 36 (2006) 779-793
73. Williams J.A., Mann F.M., and Brown N.A. Gene expression domains as markers in developmental toxicity studies using mammalian embryo culture. Int. J. Dev. Biol. 41 (1997) 359-364
74. Yoh K., Shibuya K., Morito N., Nakano T., Ishizaki K., Shimohata H., Nose M., Izui S., Shibuya A., Koyama A., Engel J.D., Yamamoto M., and Takahashi S. Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJ-Yaa genetic background. J. Am. Soc. Nephrol. 14 (2003) 2494-2502
75. Zhao G.Y., Li Z.Y., Zou H.L., Hu Z.L., Song N.N., Zheng M.H., Su C.J., and Ding Y.Q. Expression of the transcription factor GATA3 in the postnatal mouse central nervous system. Neurosci. Res. 61 (2008) 420-428